Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 483 publications

Real-World Outcomes in Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer in Argentina: A Multicenter Retrospective Study (GAOT-ALK001).

Real-World Outcomes in Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer in Argentina: A Multicenter Retrospective Study (GAOT-ALK001).

Journal: JCO global oncology
Published: October 03, 2025

Real-world costs, treatment patterns, and clinical outcomes associated with treatments for advanced anaplastic lymphoma kinase-positive non-small cell lung cancer.

Real-world costs, treatment patterns, and clinical outcomes associated with treatments for advanced anaplastic lymphoma kinase-positive non-small cell lung cancer.

Journal: Journal of managed care & specialty pharmacy
Published: August 30, 2025

Direct Ser797 Interacted Pteridine-7(8H)-one Derivatives as Highly Selective and Orally Available EGFRL858R/T790M/C797S Inhibitors.

Direct Ser797 Interacted Pteridine-7(8H)-one Derivatives as Highly Selective and Orally Available EGFRL858R/T790M/C797S Inhibitors.

Journal: Journal of medicinal chemistry
Published: August 28, 2025

Efficacy and safety of brigatinib after alectinib in patients with ALK-positive NSCLC: Integrated analysis of the ALTA-2 and J-ALTA studies.

Efficacy and safety of brigatinib after alectinib in patients with ALK-positive NSCLC: Integrated analysis of the ALTA-2 and J-ALTA studies.

Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 22, 2025

Molecular Pathogenesis, Genetic Profiles, and Therapeutic Strategies for NF2-Related Schwannomatosis

Molecular Pathogenesis, Genetic Profiles, and Therapeutic Strategies for NF2-Related Schwannomatosis

Journal: No shinkei geka. Neurological surgery
Published: August 20, 2025

Real-World Outcomes of Brigatinib Compared to Alectinib as a Second-Line Therapy After Crizotinib in Advanced Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer Patients.

Real-World Outcomes of Brigatinib Compared to Alectinib as a Second-Line Therapy After Crizotinib in Advanced Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer Patients.

Journal: Thoracic cancer
Published: August 14, 2025

Canadian Perspectives Revisited: Consensus on the management of ALK-rearranged NSCLC.

Canadian Perspectives Revisited: Consensus on the management of ALK-rearranged NSCLC.

Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 08, 2025

Real World Data on the Efficacy of Brigatinib in ALK-Positive Non-Small Cell Lung Cancer: A Single-Center Experience.

Real World Data on the Efficacy of Brigatinib in ALK-Positive Non-Small Cell Lung Cancer: A Single-Center Experience.

Journal: Cancers
Published: August 02, 2025

Patient-derived organoid facilitating personalized medicine in non-small cell lung cancer: two case reports.

Patient-derived organoid facilitating personalized medicine in non-small cell lung cancer: two case reports.

Journal: Frontiers in oncology
Published: July 28, 2025

Sex differences in cardiotoxicity of anaplastic lymphoma kinase inhibitors: An analysis of the FDA Adverse Event Reporting System.

Sex differences in cardiotoxicity of anaplastic lymphoma kinase inhibitors: An analysis of the FDA Adverse Event Reporting System.

Journal: Oncology
Published: July 24, 2025

Recent Advances in the Treatment of Non-small Cell Lung Cancer with Brigatinib

Recent Advances in the Treatment of Non-small Cell Lung Cancer with Brigatinib

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: July 10, 2025

A real-world pharmacovigilance analysis of ALK inhibitor-associated pleural and pericardial effusion using the FDA Adverse Events Reporting System (FAERS) database from 2013 to 2024.

A real-world pharmacovigilance analysis of ALK inhibitor-associated pleural and pericardial effusion using the FDA Adverse Events Reporting System (FAERS) database from 2013 to 2024.

Journal: PloS one
Published: May 19, 2025
Showing 1-12 of 483

Last Updated: 10/31/2025